by morgengold on 8/12/21, 9:45 AM with 4 comments
by smileypete on 8/12/21, 2:49 PM
'Latin America’s embrace of an unproven COVID treatment is hindering drug trials'
https://www.nature.com/articles/d41586-020-02958-2
Hopefully it would be noted in the limitations section of the trial paper, but the writers of media articles are often polarized or biased and just cherry pick.
ETA, personally I would prefer small well designed trials from researchers with historical expertise who provide plenty of accompanying information and are willing to discuss the results, eg Chaccour et al:
'The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial'
https://www.thelancet.com/journals/eclinm/article/PIIS2589-5...
https://www.youtube.com/watch?v=yIUO08W94eY https://www.youtube.com/watch?v=JuzHG0rpOrc
by velcii on 8/12/21, 11:53 AM
The part where they talk about trials like these..
https://www.youtube.com/watch?v=QAHi3lX3oGM&t=958s
Viewing full testimony is recommended.
by christmm on 8/12/21, 10:34 AM
by morgengold on 8/12/21, 9:45 AM
That’s the conclusion of the Together Trial, which has subjected several purported nonvaccine treatments for COVID-19 to carefully designed clinical testing. The trial is supervised by McMaster University in Hamilton, Canada, and conducted in Brazil ...